arrow
Back
F

François Guilhot

Centre Léon Bérard

84H-index
626Paper Count
4.3WCitation Count
Published Papers 88
Publication Date
Innate CD8 T-cells as a potential predictive biomarker for deep molecular response in chronic myeloid leukemia patients
err2025-12-19
err0
errOAAI
errEmilie Cayssials; Lucie Lefèvre; Amandine Decroos; Florence Jacomet; Nathalie Piccirilli; Florence Tartarin; François Guilhot; Jean-Claude Chomel; Philippe Rousselot; Franck E. Nicolini; Stéphanie Ragot; Jean-Marc Gombert; Lydia Roy; André Herbelin; Alice Barbarin
errShare
errSave
Long-term outcomes of tyrosine kinase inhibitors in chronic myeloid leukemia
errBLOOD
IF23.1
err2025-02-27
err2
PREAI
errGuilhot, Francois; Hehlmann, Ruediger
errShare
errSave
The EHA Research Roadmap: Malignant Myeloid Diseases
err2021-09-01
err3
errOAAI
errDoehner, Hartmut; Malcovati, Luca; Ossenkoppele, Gert J.; Hochhaus, Andreas; Vannucchi, Alessandro Maria; Bullinger, Lars; Cervantes, Francisco; Craddock, Charles; de Witte, Theo; Doehner, Konstanze; Dombret, Herve; Fenaux, Pierre; Geissler, Jan; Germing, Ulrich; Guilhot, Francois; Harrison, Claire; Hellstrom-Lindberg, Eva; Passamonti, Francesco; Sierra, Jorge; Skoda, Radek; Wierzbowska, Agnieszka
errShare
errSave
Long-term outcome of imatinib 400 mg compared to imatinib 600 mg or imatinib 400 mg daily in combination with cytarabine or pegylated interferon alpha 2a for chronic myeloid leukaemia: results from the French SPIRIT phase III randomised trial
errLEUKEMIA
IF13.4
err2021-01-22
err16
PREAI
errGuilhot, Francois; Rigal-Huguet, Francoise; Guilhot, Joelle; Guerci-Bresler, Agnes-Paule; Maloisel, Frederic; Rea, Delphine; Coiteux, Valerie; Gardembas, Martine; Berthou, Christian; Vekhoff, Anne; Jourdan, Eric; Berger, Marc; Fouillard, Loic; Alexis, Magda; Legros, Laurence; Rousselot, Philippe; Delmer, Alain; Lenain, Pascal; Escoffre Barbe, Martine; Gyan, Emmanuel; Bulabois, Claude-Eric; Dubruille, Viviane; Joly, Bertrand; Pollet, Bertrand; Cony-Makhoul, Pascale; Johnson-Ansah, Hyacinthe; Mercier, Melanie; Caillot, Denis; Charbonnier, Aude; Kiladjian, Jean-Jacques; Chapiro, Jacques; Penot, Amelie; Dorvaux, Veronique; Vaida, Iona; Santagostino, Alberto; Roy, Lydia; Zerazhi, Hacene; Deconinck, Eric; Maisonneuve, Herve; Plantier, Isabelle; Lebon, Delphine; Arkam, Yazid; Cambier, Nathalie; Ghomari, Kamel; Miclea, Jean-Michel; Glaisner, Sylvie; Cayuela, Jean-Michel; Chomel, Jean-Claude; Muller, Marc; Lhermitte, Ludovic; Delord, Marc; Preudhomme, Claude; Etienne, Gabriel; Mahon, Francois-Xavier; Nicolini, Franck- Emmanuel
errShare
errSave
The EUTOS long-term survival (ELTS) score is superior to the Sokal score for predicting survival in chronic myeloid leukemia
errLEUKEMIA
IF13.4
err2020-06-29
err45
errOAAI
errPfirrmann, Markus; Clark, Richard E.; Prejzner, Witold; Lauseker, Michael; Baccarani, Michele; Saussele, Susanne; Guilhot, Francois; Heibl, Sonja; Hehlmann, Rudiger; Faber, Edgar; Turkina, Anna; Ossenkoppele, Gert; Hoglund, Martin; Zaritskey, Andrey; Griskevicius, Laimonas; Olsson-Stromberg, Ulla; Everaus, Hele; Koskenvesa, Perttu; Labar, Boris; Sacha, Tomasz; Zackova, Daniela; Cervantes, Francisco; Colita, Adriana; Zupan, Irena; Bogdanovic, Andrija; Castagnetti, Fausto; Guilhot, Joelle; Hasford, Joerg; Hochhaus, Andreas; Hoffmann, Verena S.
errShare
errSave
Model-Based Inference and Classification of Immunologic Control Mechanisms from TKI Cessation and Dose Reduction in Patients with CML
err2020-06-02
err23
errOAAI
errHaehnel, Tom; Baldow, Christoph; Guilhot, Joelle; Guilhot, Francois; Saussele, Susanne; Mustjoki, Satu; Jilg, Stefanie; Jost, Philipp J.; Dulucq, Stephanie; Mahon, Francois-Xavier; Roeder, Ingo; Fassoni, Artur C.; Glauche, Ingmar
errShare
errSave
Low-dose tyrosine kinase inhibitors before treatment discontinuation do not impair treatment-free remission in chronic myeloid leukemia patients: Results of a retrospective study
errCANCER
IF5.1
err2020-05-27
err23
errOAAI
errCayssials, Emilie; Torregrosa-Diaz, Jose; Gallego-Hernanz, Pilar; Tartarin, Florence; Systchenko, Thomas; Maillard, Natacha; Desmier, Deborah; Machet, Antoine; Fleck, Emmanuel; Corby, Anne; Motard, Carine; Denis, Guillaume; Herbelin, Andre; Gombert, Jean-Marc; Roy, Lydia; Ragot, Stephanie; Leleu, Xavier; Guilhot, Francois; Chomel, Jean-Claude
errShare
errSave
European LeukemiaNet 2020 recommendations for treating chronic myeloid leukemia
errLEUKEMIA
IF13.4
err2020-03-03
err955
errOAAI
errHochhaus, A.; Baccarani, M.; Silver, R. T.; Schiffer, C.; Apperley, J. F.; Cervantes, F.; Clark, R. E.; Cortes, J. E.; Deininger, M. W.; Guilhot, F.; Hjorth-Hansen, H.; Hughes, T. P.; Janssen, J. J. W. M.; Kantarjian, H. M.; Kim, D. W.; Larson, R. A.; Lipton, J. H.; Mahon, F. X.; Mayer, J.; Nicolini, F.; Niederwieser, D.; Pane, F.; Radich, J. P.; Rea, D.; Richter, J.; Rosti, G.; Rousselot, P.; Saglio, G.; Saussele, S.; Soverini, S.; Steegmann, J. L.; Turkina, A.; Zaritskey, A.; Hehlmann, R.
errShare
errSave
Physicians' attitude towards selection of second line therapy with nilotinib and dasatinib in chronic myeloid leukemia patients
err2017-10-18
err0
errOAAI
errBreccia, Massimo; Baccarani, Michele; Rosti, Gianantonio; Cottone, Francesco; Cannella, Laura; Guilhot, Francois; Vignetti, Marco; Efficace, Fabio
errShare
errSave
Natural killer-cell counts are associated with molecular relapse-free survival after imatinib discontinuation in chronic myeloid leukemia: the IMMUNOSTIM study
err2017-05-18
err124
errOAAI
errRea, Delphine; Henry, Guylaine; Khaznadar, Zena; Etienne, Gabriel; Guilhot, Francois; Nicolini, Franck; Guilhot, Joelle; Rousselot, Philippe; Huguet, Francoise; Legros, Laurence; Gardembas, Martine; Dubruille, Viviane; Guerci-Bresler, Agnes; Charbonnier, Aude; Maloisel, Frederic; Ianotto, Jean-Christophe; Villemagne, Bruno; Mahon, Francois-Xavier; Moins-Teisserenc, Helene; Dulphy, Nicolas; Toubert, Antoine
errShare
errSave
Chronic Myeloid Leukemia: Immunobiology and Novel Immunotherapeutic Approaches
err2017-05-13
err12
PREAI
errCayssials, Emilie; Guilhot, Francois
errShare
errSave
Additional cytogenetic abnormalities and variant t(9;22) at the diagnosis of childhood chronic myeloid leukemia: The experience of the International Registry for Chronic Myeloid Leukemia in Children and Adolescents
errCANCER
IF5.1
err2017-05-12
err23
errOAAI
errMillot, Frederic; Dupraz, Christelle; Guilhot, Joelle; Suttorp, Meinolf; Brizard, Francoise; Leblanc, Thierry; Gunes, Adalet Meral; Sedlacek, Petr; De Bont, Evelyne; Li, Chi Kong; Kalwak, Krzysztof; Lausen, Birgitte; Culic, Srdjana; Dworzak, Michael; Kaiserova, Emilia; De Moerloose, Barbara; Roula, Farah; Biondi, Andrea; Baruchel, Andre; Guilhot, Francois
errShare
errSave
Age-related health care disparities in multiple myeloma
err2017-04-21
err9
PREAI
errPuyade, Mathieu; Defossez, Gautier; Guilhot, Francois; Leleu, Xavier; Ingrand, Pierre
errShare
errSave
Long-Term Outcomes of Imatinib Treatment for Chronic Myeloid Leukemia
err2017-03-09
err912
errOAAI
errHochhaus, Andreas; Larson, Richard A.; Guilhot, Francois; Radich, Jerald P.; Branford, Susan; Hughes, Timothy P.; Baccarani, Michele; Deininger, Michael W.; Cervantes, Francisco; Fujihara, Satoko; Ortmann, Christine-Elke; Menssen, Hans D.; Kantarjian, Hagop; O'Brien, Stephen G.; Druker, Brian J.
errShare
errSave
The Hypothesis of the Human inKT/Innate CD8(+) T-Cell Axis Applied to Cancer: Evidence for a Deficiency in Chronic Myeloid Leukemia
err2017-01-16
err15
errOAAI
errJacomet, Florence; Cayssials, Emilie; Barbarin, Alice; Desmier, Deborah; Basbous, Sara; Lefevre, Lucie; Levescot, Anais; Robin, Aurelie; Piccirilli, Nathalie; Giraud, Christine; Guilhot, Franois; Roy, Lydia; Herbelin, Andre; Gombert, Jean-Marc
errShare
errSave
Pioglitazone together with imatinib in chronic myeloid leukemia: A proof of concept study
errCANCER
IF5.1
err2016-12-27
err79
errOAAI
errRousselot, Philippe; Prost, Stephane; Guilhot, Joelle; Roy, Lydia; Etienne, Gabriel; Legros, Laurence; Charbonnier, Aude; Coiteux, Valerie; Cony-Makhoul, Pascale; Huguet, Francoise; Cayssials, Emilie; Cayuela, Jean-Michel; Relouzat, Francis; Delord, Marc; Bruzzoni-Giovanelli, Heriberto; Morisset, Laure; Mahon, Francois-Xavier; Guilhot, Francois; Leboulch, Philippe
errShare
errSave
The Rho-ROCK pathway as a new pathological mechanism of innate immune subversion in chronic myeloid leukaemia
err2016-09-29
err9
PREAI
errBasbous, Sara; Levescot, Anais; Piccirilli, Nathalie; Brizard, Francoise; Guilhot, Francois; Roy, Lydia; Bourmeyster, Nicolas; Gombert, Jean-Marc; Herbelin, Andre
errShare
errSave
Cost-effectiveness of Tyrosine Kinase Inhibitor Treatment Strategies for Chronic Myeloid Leukemia in Chronic Phase After Generic Entry of Imatinib in the United States
err2016-03-04
err78
errOAAI
errPadula, William V.; Larson, Richard A.; Dusetzina, Stacie B.; Apperley, Jane F.; Hehlmann, Rudiger; Baccarani, Michele; Eigendorff, Ekkehard; Guilhot, Joelle; Guilhot, Francois; Hehlmann, Rudiger; Mahon, Francois-Xavier; Martinelli, Giovanni; Mayer, Jiri; Muller, Martin C.; Niederwieser, Dietger; Saussele, Susanne; Schiffer, Charles A.; Silver, Richard T.; Simonsson, Bengt; Conti, Rena M.
errShare
errSave